Barbara Hickingbottom

Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma

S. Tagawa, John Smith, J. Weber, 2003, Cancer.

Preliminary safety and pharmacodynamic (PD) activity of XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in a phase I dose escalation study of patients with selected advanced solid tumors.

J. Desjarlais, R. Clynes, Caiyan Li, 2020 .

407 Preliminary safety, pharmacokinetics/pharmacodynamics, and antitumor activity of XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in patients with advanced solid tumors

Y. Najjar, A. Shields, S. Hu-Lieskovan, 2020 .

Phase I study of TH-302, an investigational hypoxia-targeted drug, and dexamethasone in patients with relapsed/refractory multiple myeloma.

J. Laubach, P. Richardson, P. Armand, 2013 .

523 Preliminary clinical experience with XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in patients with advanced solid tumors

Y. Najjar, A. Shields, S. Hu-Lieskovan, 2021, Journal for ImmunoTherapy of Cancer.